| Literature DB >> 21259006 |
Christoph Engl1, Alex Ter Beek, Martijn Bekker, Joost Teixeira de Mattos, Goran Jovanovic, Martin Buck.
Abstract
Phage shock proteins (Psp) and their homologues are found in species from the three domains of life: Bacteria, Archaea and Eukarya (e.g. higher plants). In enterobacteria, the Psp response helps to maintain the proton motive force (PMF) of the cell when the inner membrane integrity is impaired. The presumed ability of ArcB to sense redox changes in the cellular quinone pool and the strong decrease of psp induction in ΔubiG or ΔarcAB backgrounds suggest a link between the Psp response and the quinone pool. The authors now provide evidence indicating that the physiological signal for inducing psp by secretin-induced stress is neither the quinone redox state nor a drop in PMF. Neither the loss of the H(+)-gradient nor the dissipation of the electrical potential alone is sufficient to induce the Psp response. A set of electron transport mutants differing in their redox states due to the lack of a NADH dehydrogenase and a quinol oxidase, but retaining a normal PMF displayed low levels of psp induction inversely related to oxidised ubiquinone levels under microaerobic growth and independent of PMF. In contrast, cells displaying higher secretin induced psp expression showed increased levels of ubiquinone. Taken together, this study suggests that not a single but likely multiple signals are needed to be integrated to induce the Psp response.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21259006 PMCID: PMC3069315 DOI: 10.1007/s00284-011-9869-5
Source DB: PubMed Journal: Curr Microbiol ISSN: 0343-8651 Impact factor: 2.188
Strains and plasmids
| Strain or plasmid | Relevant characteristics | Reference |
|---|---|---|
| Strain | ||
| BW25113 | F-, Δ | CGSC# 7636 |
| MC1061 | F-, Δ | CGSC# 6649 |
| MG1655 | F-, | CGSC# 7740 |
| RP437 | F-, | CGSC# 12122 |
| MG1655Δ | F-, | [ |
| MVA4 | MC1061ϕ | [ |
| MVA44 | MG1655ϕ | [ |
| MVA59 | MG1655Δ | [ |
| BT3415 | RP437Δ | [ |
| BT3390 | RP437Δ | [ |
| BT3402 | BT3415Δ( | [ |
| BT3406 | BT3390Δ( | [ |
| BT3408 | BT3390 | [ |
| EC10 | RP437 ϕ | This study |
| EC11 | RP437Δ | This study |
| EC12 | RP437Δ | This study |
| EC13 | RP437Δ | This study |
| JW3901 | BW25113Δ | [ |
| EC14 | MC1061ϕ | This study |
| Plasmids | ||
| pGZ119EH | IPTG-inducible | A gift from M. Russel |
| pPMR129 | pGZ119EH harbouring | A gift from M. Russel |
| pGJ4 | IPTG-inducible P | [ |
| pGJ46 | 490 bp of | [ |
| pGJ66 | 193 bp of | This study |
Listed are the strains and plasmids used in this study
Fig. 1Measurement of psp induction by various agents. a The psp induction was measured as LacZ activity in cells containing a chromosomal ϕpspA–lacZ either in a MVA4 or b, c MVA44. a psp is induced by CCCP (40 μM for 30 min; Lane 2) and pIV from pGJ4 (leaky expression, no addition of IPTG; Lane 3 and 5), but not by KCl/Tris (Lane 4), Valinomycin (10 μM for 30 min; Lane 6) or acetate (34 mM) at pH 5 (Lane 7) or pH 7 (data not shown). KCl/Tris does not inhibit the induction of psp by pIV (Lane 5). b The effect of Valinomycin on the ability of pIV to induce psp was assessed in MVA44 (MG1655ϕpspA-lacZ) cells. Plasmid-borne pIV was set under the control of a tight IPTG-inducible promoter (pPMR129). All cells were incubated with 1 mM IPTG for 30 min. Cells in lane 2 and 4 were treated with Valinomycin (10 μM for 30 min). IPTG and Valinomycin addition occurred simultaneously. IPTG treatment in cells containing pPMR129 induced the production of the pIV secretin (Lane 3 and 4). Note that the basal level of LacZ activity in MVA44 is increased compared to MVA4 due to the native lacZ located on the chromosome of MVA44. Expression of PspA protein was assessed by immunoblotting with PspA-specific antibodies. Cells in lane 3 and 4 clearly show increased PspA production (due to the presence of pIV as determined by immunoblotting with pIV-specific antibodies). c To test, whether “time after stress” was important for induction of psp by Valinomycin, the LacZ activity in MVA44 was measured after 10 and 30 min incubation with Valinomycin (10 μM) and compared to untreated MVA44 cells. To cross-compare with results from b cells were incubated with 1 mM IPTG for the indicated length of time. Valinomycin does not induce psp after 10 and 30 min (Lane 2 and 4)
Fig. 2PMF measurement in MG1655 cells. The PMF in MG1655 was measured at mid-log phase growth using the JC-1 dye. Cells were either untreated (MG1655 ), or grown in the presence of pIV from pGJ4 (leaky expression, no addition of IPTG) (MG1655 + pIV), CCCP (40 μM for 30 min; MG1655 + CCCP), Valinomycin (10 μM for 30 min; MG1655 + Valinomycin) or simultaneously with both pIV from pGJ4 (leaky expression, no addition of IPTG) and Valinomycin (10 μM for 30 min; MG1655 + pIV + Valinomycin). Wild-type cells expressing pIV show no apparent drop in PMF compared to MG1655WT cells. CCCP and Valinomycin dissipate PMF (as seen through the marked decrease in red (590 nm) fluorescent cells). In addition, Psp effector proteins (induced by pIV) can not overcome the dissipation of PMF in presence of Valinomycin (Color figure online)
Fig. 3Ubiquinones in MG1655 and MG1655ΔpspF in absence (−) and presence (+) of pIV. The effect of pIV production from pGJ4 (leaky expression, no addition of IPTG) on the amount of oxidised (UQ8; light grey) and reduced (UQ8-H2; dark grey) ubiquinone as well as the redox state (% UQ8-H2) in wild-type MG1655 cells (with the ability to mount the Psp response) and in MG1655ΔpspF cells (lacking the PspF transcriptional activator, hence unable to mount the Psp response) are shown. Measurements were taken under aerobic and microaerobic growth conditions. Values for the standard deviation are included
Fig. 4Impact of pIV upon ArcAB activity. The impact of pIV upon ArcAB activity was assessed using a ϕpfl–lacZ reporter fusion to the ArcA-P dependent pflB promoter (pGJ46). pIV has a modest effect on pflB promoter activity. Wild-type: MG1655; ΔpspF: MG1655ΔpspF; ΔarcB: MG1655ΔarcB (MVA59). pIV was under leaky expression on pGJ4 (no addition of IPTG). Cells were grown microaerobically as described in “Material and Methods”
Fig. 5Induction of psp and the ubiquinone pool in the electron transport mutants. Comparison of (Top) the level of psp induction and (Bottom) the amount of oxidised (UQ8; light grey) and reduced (UQ8-H2; dark grey) ubiquinone as well as the redox state (% UQ8-H2) in wild-type EC10 and the electron transport mutants EC11, EC12 and EC13 under aerobic and microaerobic growth. Values for the standard deviation are included. Note that growth rates of EC11, EC12 and EC13 were similar to the parental strain EC10. Thus, the authors infer that there are no gross pleiotropic defects in these strains
Fig. 6Induction of psp by pIV in the electron transport mutants. The ability of pIV-dependent (leaky expression of pIV from pGJ4, no addition of IPTG) induction of psp in the electron transport mutants was assessed under microaerobic growth. pIV appears to have an additive effect on psp induction dependent of the basal level of induction
Fig. 7Induction of psp in EC14 (MVA4ΔmenA). The ability of pIV-dependent (leaky expression of pIV from pGJ4, no addition of IPTG) induction of psp in EC14 (Table 1) lacking menA and hence both DMK8 and MK8 was assessed under aerobic, microaerobic and anaerobic growth. The lack of menA appears to have no effect on psp induction under the growth conditions tested. White bars pIV absent, Grey bars pIV present. Values for the standard deviation are included
Fig. 8PMF measurement in the electron transport mutants. The PMF in EC10, EC11, EC12 and EC13 was measured at mid-log phase growth using the JC-1 dye. The electron transport mutants show no marked decrease in the number of red (590 nm) fluorescent cells compared to the wild-type EC10 strain indicating wild-type PMF levels of EC11, EC12 and EC13 (Color figure online)